Results 21 to 30 of about 204,163 (273)

Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia

open access: yesJournal of Microbiology, Immunology and Infection, 2021
Background: Antibiotics have been widely and efficaciously used for febrile neutropenia in pediatric patients. However, reports are scant regarding the risk factors for recurrent fever after discontinuation of antibiotics in a neutropenic state. Here, we
Ryoji Kobayashi   +6 more
doaj   +1 more source

European surveillance of infections in cancer patients - ESIC [PDF]

open access: yes, 1999
Major advances in cancer therapy result from development of multidrug chemotherapy regimens. Besides death from tumor progression, infections are currently one of the major causes of mortality and morbidity.
Buchheidt, D.   +7 more
core   +1 more source

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

open access: yesCancer Medicine, 2020
Febrile neutropenia (FN) is a critical complication of chemotherapy associated with increased in‐hospital mortality. However, associations with increased mortality and intensive care unit (ICU) admissions during longer follow‐up are not established ...
Theis Aagaard   +9 more
semanticscholar   +1 more source

Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia [PDF]

open access: yes, 2019
IMPORTANCE: Febrile neutropenia (FN) is the most common oncologic emergency and is among the most deadly. Guidelines recommend risk stratification and outpatient management of both pediatric and adult FN patients deemed to be at low risk of ...
Baugh, Christopher W.   +4 more
core   +1 more source

Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia

open access: yesEClinicalMedicine, 2020
Background Numerous paediatric febrile neutropenia (FN) clinical decision rules (CDRs) have been derived. Validation studies show reduced performance in external settings. We evaluated the association between variables common across published FN CDRs and
G. Haeusler   +6 more
semanticscholar   +1 more source

Procalcitonin as a Predictive Tool for Death and ICU Admission among Febrile Neutropenic Patients Visiting the Emergency Department

open access: yesMedicina, 2022
Background and Objectives: Risk stratification tools for febrile neutropenia exist but are infrequently utilized by emergency physicians. Procalcitonin may provide emergency physicians with a more objective tool to identify patients at risk of ...
Christopher J. Coyne   +3 more
doaj   +1 more source

Management of Febrile Neutropenia - a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer [PDF]

open access: yes, 2011
Background: Febrile neutropenia/leukopenia (FN/FL) is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy, but German data on economic consequences are limited.
Angela Ihbe-Heffinger   +19 more
core   +1 more source

Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases

open access: yesHematology Reports, 2022
The congenital immune system includes neutrophils, which perform a variety of functions. Congenital and acquired neutropenia are rare illnesses with an underestimated prevalence in children.
Sang Ngoc Nguyen   +4 more
doaj   +1 more source

Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore. [PDF]

open access: yes, 2014
BackgroundThe primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (FN) and the factors that were associated with higher direct cost.
A Bosly   +24 more
core   +2 more sources

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma [PDF]

open access: yes, 2010
Background: The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer and NHL has not been studied in ...
Gerlier, Laetitia   +13 more
core   +2 more sources

Home - About - Disclaimer - Privacy